This also results in the sector spending even more of its money on R&D than the pharmaceutical industry, with R&D spending typically in the 40%-60% range. Source: Intellectual Property and R&Dīoth pharmaceutical and biotech companies rely heavily on patents to defend their innovations, acquired through prolonged and very expensive R&D.īecause biotech companies are usually built on scientific discoveries, the sector tends to be more startup-heavy than pharmaceuticals, which are dominated by huge corporations. Ongoing surveillance aims at detecting any issues that were not detected in the clinical trials. ![]()
0 Comments
Leave a Reply. |